z-logo
open-access-imgOpen Access
Biological therapies in children with rheumatic diseases during the COVID‐19 pandemic: A single‐centre experience
Author(s) -
Aydın Fatma,
Kurt Tuba,
Sezer Müge,
Tekgöz Nilüfer,
Ekici Tekin Zahide,
Kanık Yüksek Saliha,
Çelikel Acar Banu
Publication year - 2021
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.14030
Subject(s) - medicine , etanercept , adalimumab , infliximab , tocilizumab , rheumatology , rituximab , hydroxychloroquine , pediatrics , canakinumab , population , epidemiology , arthritis , disease , anakinra , rheumatoid arthritis , covid-19 , infectious disease (medical specialty) , environmental health , lymphoma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom